Learn More
Human Proprotein Convertase 9/PCSK9 (Research Grade Alirocumab Biosimilar) Antibody, R&D Systems™

Description
Specifications
Specifications
| Antigen | Proprotein Convertase 9/PCSK9 |
| Applications | Flow Cytometry, CyTOF |
| Classification | Monoclonal |
| Clone | Hu135 |
| Conjugate | Unconjugated |
| Dilution | Intracellular Staining by Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready |
| Formulation | Lyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS. |
| Gene Alias | EC 3.4.21, EC 3.4.21.111, FH3, FH3neural apoptosis regulated convertase 1, FHCL3, HCHOLA3, hypercholesterolemia, autosomal dominant 3, LDLCQ1, NARC1, NARC-1, NARC-1convertase subtilisin/kexin type 9 preproprotein, NARC1EC 3.4.21.-, Neural apoptosis-regulated convertase 1, PC9, PCSK9, Proprotein convertase 9, proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9 |
| Host Species | Human |
| Immunogen | Human Proprotein Convertase 9/PCSK9 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.